Instituto de Investigación Sanitaria, ALS Unit

University Hospital 12 de Octubre

The ALS Unit at the Hospital 12 de Octubre in Madrid is one of the 4 ALS Units in the capital district of Spain. It is the only one in the whole country which includes a research laboratory.

University Hospital 12 de Octubre

Our principal aims are to study the genetics of the Spanish ALS population, to discover new prognostic and diagnostic biomarkers, and to develop preclinical and clinical assays.

Contact
Location
University Hospital 12 de Octubre, Avenida de Córdoba, Madrid, Spain
Contact

Our Specialists

Jesús Esteban Pérez

Principal investigator

Dr. Jesús Esteban Pérez is Principal investigator in University Hospital 12 de […]

Jesús Esteban Pérez
Current trials
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Active
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Active
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more